Challenges in the Treatment of a Refractory Testicular Germ Cell Tumor in Young Patients with Imminent Organ Failure—A Case Report
Abstract
:1. Introduction
2. Case Report
3. Discussion
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Siegel, R.L.; Miller, K.D.; Wagle, N.S.; Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 2023, 73, 17–48. [Google Scholar] [CrossRef] [PubMed]
- Oldenburg, J.; Fosså, S.D.; Nuver, J.; Heidenreich, A.; Schmoll, H.J.; Bokemeyer, C.; Horwich, A.; Beyer, J.; Kataja, V.; ESMO Guidelines Working Group. Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2013, 24, vi125-32. [Google Scholar] [CrossRef] [PubMed]
- McHugh, D.J.; Gleeson, J.P.; Feldman, D.R. Testicular cancer in 2023: Current status and recent progress. CA A Cancer J. Clin. 2024, 74, 115–203. [Google Scholar] [CrossRef]
- Barber, N.; Ali, A. Urologic Cancers (Internet); Exon Publications: Brisbane, AU, Australia, 2022. [Google Scholar]
- Surveillance, Epidemiology and End Results Program (SEER). Cancer Stat Facts: Testicular Cancer; National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program: Bethesda, MD, USA, 2022. [Google Scholar]
- Germà-Lluch, J.R.; Garcia del Muro, X.; Maroto, P.; Paz-Ares, L.; Arranz, J.A.; Gumà, J.; Alba, E.; Sastre, J.; Aparicio, J.; Fernández, A.; et al. Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: The experience of the Spanish Germ-Cell Cancer Group (GG). Eur. Urol. 2002, 42, 553–562. [Google Scholar] [CrossRef]
- Dieckmann, K.P.; Krain, J.; Gottschalk, W.; Büttner, P. Atypische Symptomatik bei Patienten mit germinalen Hodentumoren (Atypical symptoms in patients with germinal testicular tumors). Urologe A 1994, 33, 325–330. [Google Scholar] [CrossRef]
- Park, J.S.; Kim, J.; Elghiaty, A.; Ham, W.S. Recent global trends in testicular cancer incidence and mortality. Medicine 2018, 97, e12390. [Google Scholar] [CrossRef]
- Vasdev, N.; Moon, A.; Thorpe, A.C. Classification, epidemiology andtherapies for testicular germ cell tumours. Int. J. Dev. Biol. 2013, 57, 133–139. [Google Scholar] [CrossRef]
- Taylor-Weiner, A.; Zack, T.; O’Donnell, E.; Guerriero, J.L.; Bernard, B.; Reddy, A.; Han, G.C.; AlDubayan, S.; Amin-Mansour, A.; Schumacher, S.E.; et al. Genomic evolution and chemoresistance in germ-cell tumours. Nature 2016, 540, 114–118. [Google Scholar] [CrossRef]
- Fung, C.; Dinh, P.C.; Fossa, S.D.; Travis, L.B. Testicular Cancer Survivorship. J. Natl. Compr. Cancer Netw. 2019, 17, 1557–1568. [Google Scholar] [CrossRef]
- Bokemeyer, C.; Hartmann, J.T.; Kuczyk, M.A.; Truss, M.C.; Kollmannsberger, C.; Beyer, J.; Jonas, U.; Kanz, L. Recent strategies for the use of paclitaxel in the treatment of urological malignancies. World J. Urol. 1998, 16, 155–162. [Google Scholar] [CrossRef]
- Jacobs, E.M.; Muggia, F.M.; Rozencweig, M. Chemotherapy of testicular cancer: From palliation to curative adjuvant therapy. Semin. Oncol. 1979, 6, 3–13. [Google Scholar]
- Chan Wah Hak, C.; Coyle, C.; Kocache, A.; Short, D.; Sarwar, N.; Seckl, M.J.; Gonzalez, M.A. Emergency Etoposide-Cisplatin (Em-EP) for patients with germ cell tumours (GCT) and trophoblastic neoplasia (TN). BMC Cancer 2019, 19, 770. [Google Scholar] [CrossRef]
- Ulbright, T.M.; Loehrer, P.J. Choriocarcinoma-like lesions in patients with testicular germ cell tumors. Two histologic variants. Am. J. Surg. Pathol. 1998, 12, 531–541. [Google Scholar] [CrossRef] [PubMed]
- Malbari, F.; Gershon, T.R.; Garvin, J.H.; Allen, J.C.; Khakoo, Y.; Levy, A.S.; Dunkel, I.J. Psychiatric manifestations as initial presentation for pediatric CNS germ cell tumors, a case series. Child’s Nerv. Syst. 2016, 32, 1359–1362. [Google Scholar] [CrossRef]
- Emre Duygulu, M.; Kaymazli, M.; Goren, I.; Yildirim, B.; Sullu, Y.; Nural, M.S.; Bektas, A. Embryonal Testicular Cancer with Duodenal Metastasis: Could Nausea and Vomiting be Alarm Symptoms? Euroasian J. Hepatogastroenterol. 2016, 6, 198–201. [Google Scholar] [CrossRef] [PubMed]
- Al Ani, A.H.; Al Ani, H.A. Testicular seminoma metastasis to duodenum. Misdiagnosed as primary duodenal tumor. Int. J. Surg. Case Rep. 2016, 25, 149–152. [Google Scholar] [CrossRef] [PubMed]
- National Comprehensive Cancer Network. Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. Available online: https://jnccn.org/view/journals/jnccn/17/12/article-p1529.xml (accessed on 1 January 2020).
- Hinton, S.; Catalano, P.J.; Einhorn, L.H.; Nichols, C.R.; David Crawford, E.; Vogelzang, N.; Trump, D.; Loehrer, P.J., Sr. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: Final analysis of an intergroup trial. Cancer 2003, 97, 1869–1875. [Google Scholar] [CrossRef]
- Honecker, F.; Aparicio, J.; Berney, D.; Beyer, J.; Bokemeyer, C.; Cathomas, R.; Clarke, N.; Cohn-Cedermark, G.; Daugaard, G.; Dieckmann, K.P.; et al. ESMO Consensus Conference on testicular germ cell cancer: Diagnosis, treatment and follow-up. Ann. Oncol. 2018, 29, 1658–1686. [Google Scholar] [CrossRef]
- Oldenburg, J.; Berney, D.M.; Bokemeyer, C.; Climent, M.A.; Daugaard, G.; Gietema, J.A.; De Giorgi, U.; Haugnes, H.S.; Huddart, R.A.; Leão, R.; et al. Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann. Oncol. 2022, 33, 362–375. [Google Scholar] [CrossRef]
- Lorch, A.; Bascoul-Mollevi, C.; Kramar, A.; Einhorn, L.; Necchi, A.; Massard, C.; De Giorgi, U.; Fléchon, A.; Margolin, K.; Lotz, J.P.; et al. Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: Evidence from a large international database. J. Clin. Oncol. 2011, 29, 2178–2184. [Google Scholar] [CrossRef]
- Lorch, A.; Beyer, J.; Bascoul-Mollevi, C.; Kramar, A.; Einhorn, L.H.; Necchi, A.; Massard, C.; De Giorgi, U.; Fléchon, A.; Margolin, K.A.; et al. Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy. J. Clin. Oncol. 2010, 28, 4906–4911. [Google Scholar]
- Bedano, P.M.; Brames, M.J.; Williams, S.D.; Juliar, B.E.; Einhorn, L.H. Phase II Study of Cisplatin Plus Epirubicin Salvage Chemotherapy in Refractory Germ Cell Tumors. J. Clin. Oncol. 2006, 24, 5403–5407. [Google Scholar] [CrossRef] [PubMed]
- Rajpert-De Meyts, E.; Skotheim, R.I. Complex Polygenic Nature of Testicular Germ Cell Cancer Suggests Multifactorial Aetiology. Eur. Urol. 2018, 73, 832–833. [Google Scholar] [CrossRef] [PubMed]
- Bagrodia, A.; Pierorazio, P.; Singla, N.; Albers, P. The Complex and Nuanced Care for Early-stage Testicular Cancer: Lessons from the European Association of Urology and American Urological Association Testis Cancer Guidelines. Eur. Urol. 2020, 77, 139–141. [Google Scholar] [CrossRef]
- Nestler, T.; Schmelz, H.; Müller, A.C.; Seidel, C. Multimodale Therapie des Hodentumors: Wann Chemotherapie, Operation oder Strahlentherapie? (Multimodal treatment of testicular cancer: Chemotherapy, surgery or radiotherapy?). Urologie 2022, 61, 1315–1323. [Google Scholar] [CrossRef] [PubMed]
- Rosas-Plaza, X.; de Vries, G.; Meersma, G.J.; Suurmeijer, A.J.; Gietema, J.A.; van Vugt, M.A.; de Jong, S. Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment. Mol. Cancer Ther. 2020, 19, 590–601. [Google Scholar] [CrossRef]
- McGrady, M.E.; Willard, V.W.; Williams, A.M.; Brinkman, T.M. Psychological Outcomes in Adolescent and Young Adult Cancer Survivors. J. Clin. Oncol. 2024, 42, 707–716. [Google Scholar] [CrossRef]
- Kreiberg, M.; Bandak, M.; Lauritsen, J.; Andersen, K.K.; Skøtt, J.W.; Johansen, C.; Agerbaek, M.; Holm, N.V.; Lau, C.J.; Daugaard, G. Psychological stress in long-term testicular cancer survivors: A Danish nationwide cohort study. J. Cancer Surviv. 2020, 14, 72–79. [Google Scholar] [CrossRef]
Test | Results | Normal Values./Unit. Mass |
---|---|---|
-Serum Albumin | 3.32 | 3.40–4.80 |
-Total Serum Bilirubin | 3.98 | 0.10–1.00 |
-Total Serum Calcium | 8.24 | 8.60–10.20 |
-Serum Creatinine | 0.32 | 0.70–1.20 |
-Serum Potassium | 2.92 | 3.50–5.10 |
-Total Serum Proteins | 5.18 | 6.60–8.70 |
-TGO | 450.11 | Women < 32 U/L |
-TGP | 77.91 | Women < 33 U/L |
-Hemoglobin | 7.70 | 12.30–17.00 |
-BHCG | 643,648.00 | 00.00–2.60 |
-AFP | 2799.00 | 00.00–7.00 |
-INR | 1.69 | 0.86–1.20 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Pantelimon, I.; Stancu, A.-M.; Socoliuc, C.; Abzait, F.; Balescu, I.; Bacalbasa, N.; Balalau, C.; Galeș, L.N.; Brezean, I. Challenges in the Treatment of a Refractory Testicular Germ Cell Tumor in Young Patients with Imminent Organ Failure—A Case Report. J. Mind Med. Sci. 2025, 12, 30. https://doi.org/10.3390/jmms12010030
Pantelimon I, Stancu A-M, Socoliuc C, Abzait F, Balescu I, Bacalbasa N, Balalau C, Galeș LN, Brezean I. Challenges in the Treatment of a Refractory Testicular Germ Cell Tumor in Young Patients with Imminent Organ Failure—A Case Report. Journal of Mind and Medical Sciences. 2025; 12(1):30. https://doi.org/10.3390/jmms12010030
Chicago/Turabian StylePantelimon, Iuliana, Andra-Maria Stancu, Claudiu Socoliuc, Fikirie Abzait, Irina Balescu, Nicolae Bacalbasa, Cristian Balalau, Laurenţia Nicoleta Galeș, and Iulian Brezean. 2025. "Challenges in the Treatment of a Refractory Testicular Germ Cell Tumor in Young Patients with Imminent Organ Failure—A Case Report" Journal of Mind and Medical Sciences 12, no. 1: 30. https://doi.org/10.3390/jmms12010030
APA StylePantelimon, I., Stancu, A.-M., Socoliuc, C., Abzait, F., Balescu, I., Bacalbasa, N., Balalau, C., Galeș, L. N., & Brezean, I. (2025). Challenges in the Treatment of a Refractory Testicular Germ Cell Tumor in Young Patients with Imminent Organ Failure—A Case Report. Journal of Mind and Medical Sciences, 12(1), 30. https://doi.org/10.3390/jmms12010030